Histone lactylation pathway in hair cycle: deacylases and their protein targets
毛发周期中的组蛋白乳酰化途径:脱酰酶及其蛋白质靶标
基本信息
- 批准号:10412929
- 负责人:
- 金额:$ 67.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-07-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AcetylationAcetyltransferaseAreaBehaviorBiochemicalBiochemistryBioinformaticsBiologyCell physiologyCellsChemicalsChemistryChromatinCoenzyme ACultured CellsDNADataData SetDeacetylaseDiabetes MellitusDiseaseEP300 geneEnergy MetabolismEnvironmentEnzymatic BiochemistryEnzymesEpigenetic ProcessFoundationsGene Expression RegulationGenesGoalsGrowthHairHair follicle structureHistone DeacetylaseHistonesHumanHypoxiaImmune responseInfrastructureKnock-outKnowledgeLaboratoriesLysineMalignant NeoplasmsMass Spectrum AnalysisMediatingMetabolismMethylationModificationMolecularMusPathologicPathway interactionsPeriodicityPhasePhysiologicalPhysiologyPlayPositioning AttributePost-Translational Protein ProcessingProteinsProteomicsReactionRegulatory ElementRegulatory PathwayResearchRoleSiteSkinSubstrate SpecificitySystemTestingTissuesTranscriptional RegulationWarburg EffectWestern Blottingadult stem cellbasechromatin immunoprecipitationdeep sequencingepigenetic regulationexperimental studyinsightknock-downoverexpressionprogramsresponsestem cell differentiationstem cellstranscriptome sequencing
项目摘要
Emerging lines of evidence suggest an intimate crosstalk among energy metabolism, metabolites and
epigenetics. Post-translational modifications (PTMs) on histones (histone “marks”) (e.g., lysine acetylation
(Kac) and methylation (Kme)) are known to be regulated by metabolism, contributing to the epigenetic
programs that are associated with cellular physiology and disease. However, we do not yet know if additional
histone PTM pathways exist and if they can be modulated by diverse cellular metabolites. Thus, chemistry and
biochemistry of metabolites-mediated chromatin changes remain poorly characterized. Lactate, a widely known
cellular metabolite, can be dramatically induced under some cellular conditions (e.g. hypoxia) and in the
Warburg effect, an observation most commonly shared among diverse cancers and associated with many
diseases. Lactate concentration can rise to 20-40 mM in cancer tissues. Although this compound was
discovered ~200 years ago, its non-metabolic functions in physiology (e.g., hypoxia, stem cell differentiation
and immunoresponse) and disease (e.g., cancer and diabetes) remain unknown, representing a long-standing
question in biology. We recently discovered a lactate-derived, new lysine modification, lysine lactylation (Kla).
We comprehensively validated this PTM by chemical and biochemical approaches. This PTM can be
stimulated by the Warburg effect-derived lactate and has different temporal dynamics from the widely studied
lysine acetylation (Kac). Our epigenetic studies suggest that histone Kla represents a new type of metabolism-
regulated epigenetic changes and contributes to gene regulation. We hypothesize that the histone Kla pathway
is molecularly distinct from Kac pathway and contribute to gene regulation. We therefore propose to
characterize the Kla pathway by defining its key regulatory elements: enzymes that can remove the
modification (or delactylases), and their targets on histones and non-histone substrate proteins. We will also
study their role in epigenetic regulation in cyclic behavior of hair follicle stem cells (HFSCs) in which lactate and
its regulatory enzyme play a key role. We will use an integrated strategy involving chemical biology,
enzymology, quantitative proteomics, and biochemistry approaches. The knowledge gained from this study will
likely have a broad impact on our understanding of epigenetics, and will lay a foundation for studying Kla and
the Warburg effect.
新出现的证据表明能量代谢、代谢物和代谢物之间存在密切的串扰。
表观遗传学。组蛋白的翻译后修饰 (PTM)(组蛋白“标记”)(例如赖氨酸乙酰化
(Kac)和甲基化(Kme))已知受代谢调节,有助于表观遗传
与细胞生理学和疾病相关的程序。然而,我们还不知道是否需要额外的
组蛋白 PTM 通路是否存在,以及它们是否可以通过多种细胞代谢物进行调节。因此,化学和
代谢物介导的染色质变化的生物化学仍然知之甚少。乳酸,一种广为人知的
细胞代谢物,在某些细胞条件下(例如缺氧)和在
瓦尔堡效应,一种在多种癌症中最常见的现象,并且与许多癌症相关
疾病。癌症组织中的乳酸浓度可升至 20-40 mM。虽然该化合物是
约 200 年前发现,其生理学中的非代谢功能(例如缺氧、干细胞分化)
和免疫反应)和疾病(例如癌症和糖尿病)仍然未知,代表着长期存在的一个问题
生物学中的问题。我们最近发现了一种源自乳酸的新赖氨酸修饰,即赖氨酸乳酰化 (Kla)。
我们通过化学和生化方法全面验证了该 PTM。该 PTM 可以是
受到瓦尔堡效应衍生的乳酸的刺激,并且具有与广泛研究的不同的时间动态
赖氨酸乙酰化(Kac)。我们的表观遗传学研究表明,组蛋白 Kla 代表了一种新型代谢——
调节表观遗传变化并有助于基因调控。我们假设组蛋白 Kla 通路
在分子上与 Kac 途径不同,有助于基因调控。因此我们建议
通过定义其关键调控元件来表征 Kla 途径:可以去除 Kla 途径的酶
修饰(或脱乳酰酶)及其对组蛋白和非组蛋白底物蛋白的靶标。我们还将
研究它们在毛囊干细胞 (HFSC) 循环行为的表观遗传调控中的作用,其中乳酸和
其调节酶发挥关键作用。我们将采用涉及化学生物学的综合策略,
酶学、定量蛋白质组学和生物化学方法。从这项研究中获得的知识将
可能会对我们对表观遗传学的理解产生广泛的影响,并将为研究 Kla 和
瓦尔堡效应。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Hening Lin其他文献
Hening Lin的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Hening Lin', 18)}}的其他基金
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10360661 - 财政年份:2021
- 资助金额:
$ 67.55万 - 项目类别:
Histone lactylation pathway in hair cycle: deacylases and their protein targets
毛发周期中的组蛋白乳酰化途径:脱酰酶及其蛋白质靶标
- 批准号:
10623277 - 财政年份:2021
- 资助金额:
$ 67.55万 - 项目类别:
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10205726 - 财政年份:2021
- 资助金额:
$ 67.55万 - 项目类别:
Design and development of HDAC11-specific chemical inhibitors for disease treatments
用于疾病治疗的 HDAC11 特异性化学抑制剂的设计和开发
- 批准号:
10581571 - 财政年份:2021
- 资助金额:
$ 67.55万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
10613940 - 财政年份:2019
- 资助金额:
$ 67.55万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
9912164 - 财政年份:2019
- 资助金额:
$ 67.55万 - 项目类别:
Metabolite Sensing and Regulation of Protein Function
蛋白质功能的代谢传感和调节
- 批准号:
10395458 - 财政年份:2019
- 资助金额:
$ 67.55万 - 项目类别:
Screening and Development of Small Molecule HDAC11 Inhibitors to Treat Obesity and Diabetes.
治疗肥胖和糖尿病的小分子 HDAC11 抑制剂的筛选和开发。
- 批准号:
10319956 - 财政年份:2019
- 资助金额:
$ 67.55万 - 项目类别:
SIRT6 and lysine fatty acylation in macrophage inflammation
SIRT6 和赖氨酸脂肪酰化在巨噬细胞炎症中的作用
- 批准号:
9210624 - 财政年份:2016
- 资助金额:
$ 67.55万 - 项目类别:
SIRT6 and lysine fatty acylation in macrophage inflammation
SIRT6 和赖氨酸脂肪酰化在巨噬细胞炎症中的作用
- 批准号:
9009646 - 财政年份:2016
- 资助金额:
$ 67.55万 - 项目类别:
相似海外基金
Dissecting out differential molecular phenotypes across Lysine(K) AcetylTransferase mutations in mouse development
剖析小鼠发育过程中赖氨酸(K)乙酰转移酶突变的差异分子表型
- 批准号:
10727966 - 财政年份:2023
- 资助金额:
$ 67.55万 - 项目类别:
Targeting lysine acetyltransferase MOF/KAT8 in lung cancer
靶向赖氨酸乙酰转移酶 MOF/KAT8 在肺癌中的作用
- 批准号:
10601761 - 财政年份:2023
- 资助金额:
$ 67.55万 - 项目类别:
Roles of lysine acetyltransferase 6 complexes in cerebral development and neurodevelopmental disorders
赖氨酸乙酰转移酶 6 复合物在大脑发育和神经发育障碍中的作用
- 批准号:
479754 - 财政年份:2023
- 资助金额:
$ 67.55万 - 项目类别:
Operating Grants
Defining the cell-type specific role of histone acetyltransferase KAT2a in nucleus accumbens D1 medium spiny neurons as a driver of cocaine use disorder
定义组蛋白乙酰转移酶 KAT2a 在伏隔核 D1 中型多棘神经元中作为可卡因使用障碍驱动因素的细胞类型特异性作用
- 批准号:
10679238 - 财政年份:2023
- 资助金额:
$ 67.55万 - 项目类别:
Examination of the Histone Acetyltransferase CBP in the Remodelling of Thermogenic Adipose Tissues
组蛋白乙酰转移酶 CBP 在生热脂肪组织重塑中的检测
- 批准号:
486467 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Studentship Programs
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10344246 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Nuclear activity of carnitine acetyltransferase
肉毒碱乙酰转移酶的核活性
- 批准号:
RGPIN-2018-06089 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Discovery Grants Program - Individual
Development of p300/CBP histone acetyltransferase inhibitors for oncogene-driven cancers
开发用于癌基因驱动癌症的 p300/CBP 组蛋白乙酰转移酶抑制剂
- 批准号:
10627744 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Characterizing the role of the NuA3 histone acetyltransferase complex during transcription
表征 NuA3 组蛋白乙酰转移酶复合物在转录过程中的作用
- 批准号:
557615-2021 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Postdoctoral Fellowships
Structural and functional studies of histone acetyltransferase complexes
组蛋白乙酰转移酶复合物的结构和功能研究
- 批准号:
RGPIN-2018-03951 - 财政年份:2022
- 资助金额:
$ 67.55万 - 项目类别:
Discovery Grants Program - Individual














{{item.name}}会员




